Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Chemed stock price, quote, forecast and news

CHE
US16359R1032
A0CBF4

Price

537.12
Today +/-
+0
Today %
+0 %
P

Chemed Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Chemed, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Chemed from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Chemed’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Chemed. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Chemed’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Chemed’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Chemed’s growth potential.

Chemed Revenue, EBIT and net profit per share

DateChemed RevenueChemed EBITChemed Net Income
2026e2.79 B undefined517.76 M undefined406.9 M undefined
2025e2.62 B undefined474.4 M undefined386.52 M undefined
2024e2.45 B undefined421.98 M undefined354.91 M undefined
20232.26 B undefined360.92 M undefined272.51 M undefined
20222.14 B undefined345 M undefined249.6 M undefined
20212.14 B undefined361.5 M undefined268.6 M undefined
20202.08 B undefined331.4 M undefined319.5 M undefined
20191.94 B undefined274.8 M undefined219.9 M undefined
20181.78 B undefined245.2 M undefined205.5 M undefined
20171.67 B undefined216.3 M undefined98.2 M undefined
20161.58 B undefined186.1 M undefined108.7 M undefined
20151.54 B undefined189.6 M undefined110.3 M undefined
20141.46 B undefined173.6 M undefined99.3 M undefined
20131.41 B undefined140.5 M undefined77.2 M undefined
20121.43 B undefined161.1 M undefined89.3 M undefined
20111.36 B undefined153.7 M undefined86 M undefined
20101.28 B undefined145.7 M undefined81.8 M undefined
20091.19 B undefined130.9 M undefined73.8 M undefined
20081.15 B undefined135.6 M undefined67.3 M undefined
20071.1 B undefined121.7 M undefined61.6 M undefined
20061.02 B undefined105 M undefined50.7 M undefined
2005916 M undefined76.8 M undefined35.8 M undefined
2004734.9 M undefined57.9 M undefined27.5 M undefined

Chemed Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
0.270.30.330.360.390.50.330.340.350.40.530.650.270.30.340.380.450.360.340.310.260.730.921.021.11.151.191.281.361.431.411.461.541.581.671.781.942.082.142.142.262.452.622.79
-10.997.5910.128.9127.88-34.203.343.5313.9230.9222.86-58.1411.4813.2911.7316.80-20.22-5.07-6.82-17.20182.3124.8011.148.064.363.667.565.945.46-1.193.045.982.145.716.968.757.282.89-0.196.048.396.766.53
62.6457.1056.1356.2755.7548.8033.4334.7134.9434.4133.3333.6438.1539.2037.8337.8039.1041.1339.1740.4543.8531.0629.5928.2930.2729.4429.8329.2228.3927.6928.5928.9129.4929.2530.9731.0931.8433.7235.9535.8335.25---
171173183202218244110118123138175217103118129144174146132127114228271288333338355374385396404421455461516554617701769765798000
333637384343111110152329141719202629131785776105121135130145153161140173189186216245274331361345360421474517
12.0911.8811.3510.5811.008.603.343.242.843.744.384.505.195.655.575.255.848.173.865.413.087.778.3010.3111.0011.7610.9211.3311.2811.269.9111.8812.2511.8012.9713.7514.1415.9216.8816.1615.9017.1618.0918.52
182021372024261653151943233230191920-12-2-3273550616773818689779911010898205219319268249272354386406
-11.115.0076.19-45.9520.008.33-38.46231.25-71.7026.67126.32-46.5139.13-6.25-36.67-5.26-160.00-83.3350.00-1,000.0029.6342.8622.009.848.9610.966.173.49-13.4828.5711.11-1.82-9.26109.186.8345.66-15.99-7.099.2430.159.045.18
--------------------------------------------
--------------------------------------------
162221.927.12221.820.12120.119.619.619.719.819.82020.22120.619.419.719.824.626.326.725.123.422.72320.919.318.617.817.416.816.716.816.516.415.915.115.2000
--------------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Chemed Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Chemed is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Chemed provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Chemed's financial health and stability.

Assets

Chemed's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Chemed must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Chemed after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Chemed's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
18171862020261653151943233230191920-12-2-3273550616773818689779911010898205219319268249272
10111314161967891315101115171920211091821222527272929303230333435384556595960
000012000-1110-2-1300-6015-576-25-27-3-776-625-237-15-3-8
-145-8-9-19-9-511-2-7-8-1134-9-971122712-3-21-224-4727-823-496-24-1317945-25-33-38
73411331816-41-5-8-28-1-8-15-10-222919141516223129383332313429223351324448446473
00010689775888109767743171916155444540003442132
000142311111136119281826368146502-1393245040494453554462604294461996573
2237282322374640201517231936332027513429239280989911216086174131150110171135162287301489308309330
-5-8-7-18-18-25-7-7-11-8-13-18-9-11-20-22-22-17-14-8-10-18-25-22-26-26-21-25-29-35-29-43-44-39-64-52-53-58-58-57-56
-201039-20-47-26-1519-270-519-84126-25-32-31-1941-7-353-41-27-31-28-22-35-34-40-31-43-50-39-67-105-190-61-57-59-60
-14191027-2-22-18-830-19131329-73146-3-10-13-4492-334-16-5-5-2-1-10-4-5-20-60-3-52-137-20-2-3
00000000000000000000000000000000000000000
-55-10-10029012-7443-8-163-66-27-17-11-35-1199-49-8218-11-20001-11-29-57160-13-3-99196-99-81
19718103115120000000001398123200581217-88-43-93-67-126-58-125-540-6934
8-10-6-14-2411-19-26-3420-16-27-2441-102-25-19-27-16-41-2281-52-98-92-84-29-112-152-59-104-137-120-94-99-188-109-271-380-209-79
4-9-10-13-3-3-24-8-6-10-2-2-150-4-6-1-30-11-8-14-107-68-1-105-146-60-96-4-3-1-13-29-28-25-15-18-9
-10-13-13-14-14-16-18-20-19-19-19-20-20-20-21-21-22-4-4-4-4-5-6-6-5-5-8-11-12-13-14-14-15-16-17-18-19-21-22-22-23
9382618-2200-1580-915-656-29-24-7-1291320-14-27-24-1108-62-113114-7000-4-61156-12941189
16.328.721.44.83.711.539.233.48.87.73.8510.225.613.3-1.25.534.219.921.313.474.654.376.67386139.360.4144.796.5121.566.7127.495.698.2234.2248.2430.5249.9252.6273.45
00000000000000000000000000000000000000000

Chemed stock margins

The Chemed margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Chemed. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Chemed.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Chemed's sales revenue. A higher gross margin percentage indicates that the Chemed retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Chemed's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Chemed's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Chemed's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Chemed. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Chemed's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Chemed Margin History

Chemed Gross marginChemed Profit marginChemed EBIT marginChemed Profit margin
2026e35.28 %18.55 %14.58 %
2025e35.28 %18.11 %14.75 %
2024e35.28 %17.2 %14.46 %
202335.28 %15.94 %12.03 %
202235.84 %16.16 %11.69 %
202135.98 %16.9 %12.56 %
202033.73 %15.94 %15.36 %
201931.85 %14.18 %11.34 %
201831.08 %13.76 %11.53 %
201730.97 %12.98 %5.89 %
201629.27 %11.8 %6.89 %
201529.53 %12.28 %7.15 %
201428.95 %11.92 %6.82 %
201328.62 %9.94 %5.46 %
201227.74 %11.27 %6.24 %
201128.43 %11.33 %6.34 %
201029.25 %11.38 %6.39 %
200929.89 %11 %6.2 %
200829.45 %11.8 %5.86 %
200730.27 %11.06 %5.6 %
200628.32 %10.31 %4.98 %
200529.64 %8.38 %3.91 %
200431.04 %7.88 %3.74 %

Chemed Stock Sales Revenue, EBIT, Earnings per Share

The Chemed earnings per share therefore indicates how much revenue Chemed has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Chemed earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Chemed's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Chemed’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Chemed's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Chemed Revenue, EBIT and net profit per share

DateChemed Sales per ShareChemed EBIT per shareChemed Earnings per Share
2026e184.35 undefined0 undefined26.88 undefined
2025e173.05 undefined0 undefined25.53 undefined
2024e162.09 undefined0 undefined23.44 undefined
2023148.97 undefined23.74 undefined17.93 undefined
2022141.39 undefined22.85 undefined16.53 undefined
2021134.55 undefined22.74 undefined16.89 undefined
2020126.8 undefined20.21 undefined19.48 undefined
2019117.49 undefined16.65 undefined13.33 undefined
2018106.11 undefined14.6 undefined12.23 undefined
201799.8 undefined12.95 undefined5.88 undefined
201693.86 undefined11.08 undefined6.47 undefined
201588.7 undefined10.9 undefined6.34 undefined
201481.81 undefined9.75 undefined5.58 undefined
201375.98 undefined7.55 undefined4.15 undefined
201274.09 undefined8.35 undefined4.63 undefined
201164.88 undefined7.35 undefined4.11 undefined
201055.67 undefined6.33 undefined3.56 undefined
200952.43 undefined5.77 undefined3.25 undefined
200849.1 undefined5.79 undefined2.88 undefined
200743.83 undefined4.85 undefined2.45 undefined
200638.15 undefined3.93 undefined1.9 undefined
200534.83 undefined2.92 undefined1.36 undefined
200429.87 undefined2.35 undefined1.12 undefined

Chemed business model

Chemed Corp is an American company headquartered in Cincinnati, Ohio. It was founded in 1970 and has since become a leading provider of healthcare services. The company operates in two main business segments: Roto-Rooter and VITAS Healthcare. Roto-Rooter offers a wide range of plumbing, drainage, and sewer services, while VITAS Healthcare provides hospice and palliative care services. Chemed Corp also offers various everyday use products. The company has received numerous awards and recognitions and has plans to expand its services to new areas and markets through organic growth and targeted acquisitions. Overall, Chemed Corp has a strong business model and a diverse range of products and services tailored to consumer needs worldwide. Chemed is one of the most popular companies on Eulerpool.com.

Chemed SWOT Analysis

Strengths

Chemed Corp possesses several key strengths that contribute to its success:

  • Strong brand reputation
  • Diverse portfolio of services
  • Experienced and skilled workforce
  • High customer satisfaction

Weaknesses

Despite its strengths, Chemed Corp also faces certain weaknesses:

  • Dependence on a few major customers
  • Limited geographical reach
  • Reliance on regulatory approvals
  • Higher prices compared to competitors

Opportunities

Chemed Corp can explore several opportunities to further grow its business:

  • Expansion into new markets
  • Acquisition of complementary businesses
  • Increased demand for healthcare services
  • Technological advancements in the industry

Threats

Chemed Corp should also be aware of potential threats that may impact its operations:

  • Intense competition in the healthcare sector
  • Changes in government regulations
  • Economic downturns affecting consumer spending
  • Labor shortages and rising labor costs

Chemed historical P/E ratio, EBIT, and P/S ratio.

Chemed shares outstanding

The number of shares was Chemed in 2023 — This indicates how many shares 15.2 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Chemed earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Chemed's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Chemed’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Chemed's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Chemed Stock splits

In Chemed's history, there have been no stock splits.

Chemed dividend history and estimates

In 2023, Chemed paid a dividend amounting to 1.56 USD. Dividend means that Chemed distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Chemed provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Chemed’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Chemed's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Chemed Dividend History

DateChemed Dividend
2026e2.01 undefined
2025e2.01 undefined
2024e2.01 undefined
20231.56 undefined
20221.48 undefined
20211.4 undefined
20201.32 undefined
20191.24 undefined
20181.16 undefined
20171.08 undefined
20161 undefined
20150.92 undefined
20140.84 undefined
20130.76 undefined
20120.68 undefined
20110.6 undefined
20100.52 undefined
20090.36 undefined
20080.24 undefined
20070.24 undefined
20060.24 undefined
20050.24 undefined
20040.24 undefined

Chemed dividend payout ratio

In 2023, Chemed had a payout ratio of 8.01%. The payout ratio indicates the percentage of the company's profits that Chemed distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Chemed represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Chemed could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Chemed's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Chemed Payout Ratio History

DateChemed Payout ratio
2026e8.29 %
2025e8.46 %
2024e8.42 %
20238.01 %
20228.95 %
20218.29 %
20206.78 %
20199.32 %
20189.48 %
201718.37 %
201615.43 %
201514.53 %
201415.08 %
201318.27 %
201214.72 %
201114.63 %
201014.65 %
200911.04 %
20088.36 %
20079.8 %
200612.7 %
200517.39 %
200421.62 %
Unfortunately, there are currently no price targets and forecasts available for Chemed.

Chemed latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
3/31/20245.53 5.2  (-6.05 %)2024 Q1
12/31/20236.31 6.6  (4.55 %)2023 Q4
9/30/20234.95 5.32  (7.5 %)2023 Q3
6/30/20235.14 4.71  (-8.32 %)2023 Q2
3/31/20234.86 4.82  (-0.78 %)2023 Q1
12/31/20225.37 5.39  (0.38 %)2022 Q4
9/30/20224.69 4.74  (1 %)2022 Q3
6/30/20224.82 4.84  (0.32 %)2022 Q2
3/31/20224.52 4.79  (6.02 %)2022 Q1
12/31/20215.13 5.25  (2.39 %)2021 Q4
1
2
3
4
5
...
9

Eulerpool ESG Scorecard© for the Chemed stock

Eulerpool World ESG Rating (EESG©)

73/ 100

🌱 Environment

82

👫 Social

65

🏛️ Governance

73

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Chemed list of shareholders

%
Name
Stocks
Change
Date
8.39 % BlackRock Institutional Trust Company, N.A.1,270,8781,69612/31/2023
3.59 % Kayne Anderson Rudnick Investment Management, LLC543,4949,37112/31/2023
3.42 % Neuberger Berman, LLC518,415-2,46912/31/2023
3.34 % Durable Capital Partners LP505,42722,35912/31/2023
3.15 % William Blair Investment Management, LLC476,446-54,36312/31/2023
3.03 % State Street Global Advisors (US)458,54914,32512/31/2023
11.20 % The Vanguard Group, Inc.1,696,2161,78012/31/2023
1.85 % Geode Capital Management, L.L.C.279,4008,59412/31/2023
1.71 % Impax Asset Management Ltd.258,992-52,19912/31/2023
1.54 % Wellington Management Company, LLP232,517-153,72012/31/2023
1
2
3
4
5
...
10

Chemed Executives and Management Board

Mr. Kevin Mcnamara69
Chemed President, Chief Executive Officer, Director (since 1986)
Compensation 11.61 M
Mr. Nicholas Westfall44
Chemed Executive Vice President
Compensation 4.2 M
Mr. Spencer Lee67
Chemed Executive Vice President (since 1999)
Compensation 3.61 M
Mr. Michael Witzeman52
Chemed Chief Financial Officer, Controller
Compensation 2.22 M
Mr. George Walsh77
Chemed Independent Chairman of the Board
Compensation 391,018
1
2
3

Most common questions regarding Chemed

What values and corporate philosophy does Chemed represent?

Chemed Corp is a company known for exemplifying values of integrity, excellence, and innovation. With a strong corporate philosophy, Chemed prioritizes a customer-centric approach, constantly striving to meet and exceed their expectations. Their commitment to ethical practices and the highest standards in healthcare services distinguish them in the industry. Chemed also emphasizes the importance of fostering a positive work environment, valuing their employees and promoting professional growth. By consistently delivering exceptional results, Chemed reflects a dedication to long-term success and sustainable progress.

In which countries and regions is Chemed primarily present?

Chemed Corp is primarily present in the United States.

What significant milestones has the company Chemed achieved?

Chemed Corp has achieved several significant milestones throughout its history. The company experienced strong growth and expanded its services, becoming a leader in the healthcare industry. Chemed Corp's subsidiary, VITAS Healthcare, has reached noteworthy achievements, including the provision of compassionate end-of-life care to thousands of patients and their families. Additionally, Chemed Corp successfully acquired and integrated various companies, enhancing its business portfolio and market presence. The company's commitment to innovation, quality care, and strategic acquisitions has contributed to its continued success and recognition within the industry.

What is the history and background of the company Chemed?

Chemed Corp is a renowned company with a rich history and compelling background. Established in 1970, Chemed Corp began as a provider of plumbing and drain cleaning services through its Roto-Rooter subsidiary. Over the years, it expanded its operations and diversified into healthcare services. Currently, Chemed Corp is a leading provider of hospice and palliative care services through its subsidiary, VITAS Healthcare. The corporation's commitment to exceptional patient care has earned it a stellar reputation in the healthcare industry. Chemed Corp continues to grow and flourish, upholding its core values and consistently delivering outstanding services to those in need.

Who are the main competitors of Chemed in the market?

The main competitors of Chemed Corp in the market include companies such as Amedisys Inc, Brookdale Senior Living Inc, and Encompass Health Corporation.

In which industries is Chemed primarily active?

Chemed Corp is primarily active in the healthcare and service industries.

What is the business model of Chemed?

The business model of Chemed Corp focuses on providing end-of-life care services through its subsidiaries, VITAS Healthcare and Roto-Rooter. Chemed Corp operates in two segments: VITAS, which offers hospice services to patients with life-limiting illnesses, and Roto-Rooter, a leading provider of plumbing and drain cleaning services. VITAS prioritizes compassionate care, aiming to enhance quality of life for patients and support their families. Roto-Rooter, on the other hand, provides essential plumbing solutions, specializing in emergency repairs, maintenance, and installation services. Chemed Corp's business model emphasizes delivering high-quality and specialized services in the healthcare and plumbing sectors, positioning itself as a reliable and trusted provider.

What is the P/E ratio of Chemed 2024?

The Chemed P/E ratio is 23.

What is the P/S ratio of Chemed 2024?

The Chemed P/S ratio is 3.33.

What is the AlleAktien quality score of Chemed?

The AlleAktien quality score for Chemed is 7/10.

What is the revenue of Chemed 2024?

The expected Chemed revenue is 2.45 B USD.

How high is the profit of Chemed 2024?

The expected Chemed profit is 354.91 M USD.

What is the business model of Chemed

Chemed Corp is a US-based company operating in the hospice and drain cleaning sectors. It was founded in 1970 and is headquartered in Cincinnati, Ohio. Hospice services: Chemed Corp is the parent company of Vitas Healthcare, one of the largest hospice providers in the US. Vitas Healthcare offers a wide range of services for patients with life-threatening illnesses, including home care, support for family members and caregivers, pain therapy, and emotional support. Vitas Healthcare has a nationwide network of hospice centers and is a preferred hospice provider for Medicare, Medicaid, and private insurance companies. The company has also built partnerships with hospitals and nursing facilities to provide its customers access to top-quality care. Drain cleaning services: Chemed Corp also operates Roto-Rooter, one of the leading drain cleaning and plumbing companies in North America. The company offers a wide range of services, including pipe cleaning, sewer rehabilitation, and inspections of residential and commercial areas. Roto-Rooter is available 24/7 and offers emergency services. The company has also built a network of franchisees offering their services in multiple countries worldwide. Other business areas: In addition, Chemed Corp also operates milk production management consulting through its subsidiary Agri-Best. The company provides consulting services for dairy farms and assists with diets and feeding plans for dairy cows, among other services. Products: Chemed Corp offers a wide range of products for the hospice and drain cleaning sectors. For example, Vitas Healthcare offers medical supply products for customers and their environments, including respiratory aids, medical devices, and infusion pumps. Roto-Rooter offers plumbing products such as drain cleaners and pipes. Summary: Chemed Corp is a company operating in the hospice and drain cleaning sectors. The company offers a wide range of services and operates subsidiaries such as Vitas Healthcare and Roto-Rooter. Chemed Corp is also active in other business areas such as dairy management. The company offers a variety of products relevant to its different business sectors.

What is the Chemed dividend?

Chemed pays a dividend of 1.48 USD distributed over 4 payouts per year.

How often does Chemed pay dividends?

Chemed pays out a dividend 4 times a year.

What is the Chemed ISIN?

The ISIN of Chemed is US16359R1032.

What is the Chemed WKN?

The WKN of Chemed is A0CBF4.

What is the Chemed ticker?

The ticker of Chemed is CHE.

How much dividend does Chemed pay?

Over the past 12 months, Chemed paid a dividend of 1.56 USD . This corresponds to a dividend yield of about 0.29 %. For the coming 12 months, Chemed is expected to pay a dividend of 2.01 USD.

What is the dividend yield of Chemed?

The current dividend yield of Chemed is 0.29 %.

When does Chemed pay dividends?

Chemed pays a quarterly dividend. This is distributed in the months of September, December, March, June.

How secure is the dividend of Chemed?

Chemed paid dividends every year for the past 23 years.

What is the dividend of Chemed?

For the upcoming 12 months, dividends amounting to 2.01 USD are expected. This corresponds to a dividend yield of 0.37 %.

In which sector is Chemed located?

Chemed is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chemed kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chemed from 6/18/2024 amounting to 0.4 USD, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.

When did Chemed pay the last dividend?

The last dividend was paid out on 6/18/2024.

What was the dividend of Chemed in the year 2023?

In the year 2023, Chemed distributed 1.48 USD as dividends.

In which currency does Chemed pay out the dividend?

The dividends of Chemed are distributed in USD.

All fundamentals about Chemed

Our stock analysis for Chemed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chemed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.